Category Archives: Europe

PPRS Payments Now Worth £150m in the UK

By Leela Barham. A second payment has now been made under the UK’s Pharmaceutical Price Regulation Scheme (PPRS). Adding a further £76m to the £74m for the first quarter of 2014, the payments received by the Department of Health (DH) now total £150m (US$244m).  Payments are a new feature of the long-standing voluntary PPRS. The […]
Also posted in Guest Blog, Op-Ed, pricing, Regulatory | Tagged , , | Leave a comment

Scottish Life Science Sector’s Referendum Concerns

As the ‘Yes-to-Scottish-independence’ vote gathers strength in the run-up to this week’s historic referendum, some the UK’s big business players last week warned of adverse consequences if Scotland breaks away from the United Kingdom. Most controversially, the Royal Bank of Scotland (RBS) declared that a vote for independence would see it forced to relocate its […]
Also posted in Biotech, Global, R&D | Tagged , , , , | Leave a comment

European Pharma: Paying the Price of Pharmacovigilance

Pharmacovigilance controls are becoming firmly embedded in the European Union’s post-authorization regulatory system, with the European Medicines Agency (EMA) acting as the pivot for an EU-wide network of agencies monitoring medicines throughout their market lifespan. T he new pharmacovigilance activities stemming from the EU legislation, the first stage of which was approved four years ago, […]
Also posted in Regulatory, Safety | Tagged , , | Leave a comment

BMS and Merck Race to Melanoma Treatment Market

Merck’s Keytruda, recently approved in the US to treat patients with advanced melanoma that have stopped responding to other cancer therapies, will soon face strong competition from Bristol-Myers Squibb’s (BMS) Opdivo,  an analyst from research and consulting firm GlobalData has reported.
Also posted in Global, Strategy | Tagged , , , , | Leave a comment

EFPIA Efforts to Block Stolen Drugs in European Supply Chain

The European Federation of Pharmaceutical Industries and Associations’ new medicines verification system will put an end to the re-sale of stolen and counterfeit drugs in the European supply chain, the organisation claims. The European Stakeholder Model (ESM) reportedly offers a cost-effective technological solution using anti-tampering device together with 2D barcoding to verify the authenticity of medicinal products. Because of loopholes […]
Also posted in Global, Safety, Supply Chain, Technology | Tagged , , , , | Leave a comment
  • Categories

  • Meta